Development and validation of a cardiovascular risk prediction model in type 1 diabetes
Conclusions/interpretationA prediction tool such as that developed here can provide individualised risk predictions. This 10 year CVD risk prediction tool could facilitate patient discussions regarding appropriate statin prescribing. Apart from 10 year risk, such discussions may also consider longer-term CVD risk, the potential for greater benefits from early vs later statin intervention, the potential impact on qualit y of life of an early CVD event and evidence on safety, all of which could influence treatment decisions, particularly in younger people with type 1 diabetes.Graphical abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Type 1 | Endocrinology | Heart | Scotland Health | Statin Therapy | Statistics | Sweden Health | Women